seed
Stage
2023
Founded
1
Investors
About
Seamless Therapeutics develops a gene-editing platform using programmable recombinases to enable precise, large DNA edits in the human genome, targeting genetic diseases with reduced off-target effects.
Explore Seamless Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.